Short Interest in Moolec Science SA (NASDAQ:MLEC) Rises By 128.4%

Moolec Science SA (NASDAQ:MLEC) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totaling 20,742 shares, a growth of 128.4% from the May 31st total of 9,082 shares. Based on an average daily volume of 37,357 shares, the short-interest ratio is currently 0.6 days. Approximately 3.6% of the company’s stock are sold short.

Analysts Set New Price Targets

Separately, Wall Street Zen raised Moolec Science from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Moolec Science stock. Citadel Advisors LLC purchased a new stake in Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science as of its most recent filing with the SEC. 0.07% of the stock is owned by hedge funds and other institutional investors.

Moolec Science Stock Performance

Shares of MLEC remained flat at $7.47 during trading hours on Wednesday. The stock had a trading volume of 6,062 shares, compared to its average volume of 803,952. The company’s 50-day moving average is $7.91 and its two-hundred day moving average is $7.60. The company has a quick ratio of 0.08, a current ratio of 0.15 and a debt-to-equity ratio of 0.79. The stock has a market capitalization of $5.45 million, a PE ratio of -0.23 and a beta of 0.28. Moolec Science has a 12-month low of $3.08 and a 12-month high of $100.20.

Moolec Science (NASDAQ:MLEC) last announced its quarterly earnings data on Thursday, May 14th. The company reported $47.49 EPS for the quarter. The firm had revenue of $2.62 million for the quarter.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.